Intervention

Endoscopic sleeve gastroplasty

ClinicalTrials.gov intervention label

Clinical trials7

Recruiting0

Common conditions10

Lead sponsors shown6

Clinical trials

7 shown

Hormonal and Microbiota Modulation After Endoscopic Sleeve GastroplastyNCT07576777 · 2026-05-04

NOT_YET_RECRUITING

Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)NCT07449520 · 2026-03-01

NOT_YET_RECRUITING

Endoscopic Sleeve Gastroplasty Versus GLP-1 Analogue for Class 1 and 2 Obesity StudyNCT05569304 · 2022-10-07

Endoscopic Sleeve Gastroplasty for Obesity and Microbiota Randomized TrialNCT04200144 · 2020-02-04

ESG vs LSG: Short-term Nutritional OutcomesNCT04264364 · 2019-06-16

Endoscopic Sleeve GastroplastyNCT02948621 · 2016-10-01

Endoscopic Sleeve Gastroplasty for Treatment of ObesityNCT02231970 · 2014-09-01

Common conditions

Obesity5 Endoscopic Sleeve Gastroplasty2 Gastric Hormones1 Gastric Motility1 Laparoscopic Sleeve Gastrectomy1 Metabolic Disorders1 Microbiota1 Morbid Obesity1 Obesity (Disorder)1 Quality of Life1

Leading sponsors

IHU Strasbourg2 Assistance Publique - Hôpitaux de Paris1 Fondazione Policlinico Universitario Agostino Gemelli IRCCS1 Grupo Hospital de Madrid1 King Saud University1 Sengkang General Hospital1

Trial status mix

UNKNOWN3

COMPLETED2

NOT_YET_RECRUITING2

Phase mix

NA4

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.